advertisement
Fechtner RD 4
Showing records 1 to 4 | Display all abstracts from Fechtner RD10099 The uniocular drug trial and second-eye response to glaucoma medications
Realini T; Fechtner RD; Atreides SP; Gollance S
Ophthalmology 2004; 111: 421-426
10093 Fixed combinations of topical glaucoma medications
Fechtner RD; Realini T
Current Opinions in Ophthalmology 2004; 15: 132-135
10122 Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
Whitson JT; Henry C; Hughes B; Lee DA; Terry S; Fechtner RD
Journal of Glaucoma 2004; 13: 168-173
10139 Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials
Fechtner RD; Airaksinen PJ; Getson AJ; Lines CR; Adamsons IA; COSOPT versus XALATAN Study Groups
Acta Ophthalmologica Scandinavica 2004; 82: 42-48
